iBio, Inc.
IBIO
$4.55
-$0.31-6.38%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 200.00K | -- | 175.00K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 200.00K | -- | 175.00K | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 200.00K | -- | 175.00K | -- | -- |
| SG&A Expenses | 2.74M | 2.80M | 2.44M | 2.72M | 2.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.62M | 4.11M | 3.58M | 3.63M | 4.50M |
| Operating Income | -4.42M | -4.11M | -3.41M | -3.63M | -4.50M |
| Income Before Tax | -4.36M | -3.99M | -3.25M | -2.64M | -4.49M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.36M | -3.99M | -3.25M | -2.64M | -4.49M |
| Earnings from Discontinued Operations | -- | -- | -4.53M | -537.00K | -3.72M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.36M | -3.99M | -7.78M | -3.17M | -8.21M |
| EBIT | -4.42M | -4.11M | -3.41M | -3.63M | -4.50M |
| EBITDA | -4.22M | -3.91M | -3.18M | -3.39M | -4.26M |
| EPS Basic | -0.48 | -0.46 | -0.91 | -0.85 | -4.42 |
| Normalized Basic EPS | -0.30 | -0.29 | -0.24 | -0.61 | -1.51 |
| EPS Diluted | -0.48 | -0.46 | -0.91 | -0.85 | -4.42 |
| Normalized Diluted EPS | -0.30 | -0.29 | -0.24 | -0.61 | -1.51 |
| Average Basic Shares Outstanding | 9.13M | 8.63M | 8.58M | 3.71M | 1.86M |
| Average Diluted Shares Outstanding | 9.13M | 8.63M | 8.58M | 3.71M | 1.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
